BARROW ROBERT (Chief Executive Officer) received a stock award from DEFINIUM THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/22/2026ACC: 0001193125-26-276882
DirectorOfficer· Chief Executive Officer
Since Jan 2022
+375K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
375K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+375K
Price / share
—
Trade value
—
% of position
49.8%
6/22/2026
752.45K→1.13M
Total
Net shares
+375K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/22/2026 | A · Award | +375K | — | — | 49.8% | 752.45K | 1.13M |
| Total | +375K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported